Epigenetic
Alterations
Your DNA sequence doesn’t change — but which genes are active does. Methylation patterns drift with age, silencing youthful genes and reactivating pro-aging ones. Horvath’s clock reads this drift to the year.
The Mechanism
The epigenetic clock — and why it’s partially reversible
Epigenetic aging is the progressive drift of DNA methylation patterns away from youthful states. CpG sites — dinucleotide positions where a cytosine precedes a guanine — can be methylated (gene-silencing) or unmethylated (gene-activating). In young cells, this pattern is tightly regulated by DNMT3 (methylation) and TET (demethylation) enzymes.
With age, three disruptions occur simultaneously: global hypomethylation— transposable elements and repetitive sequences are de-repressed, fueling genomic instability; promoter hypermethylation — tumor suppressors and longevity genes are silenced; and heterochromatin dissolution — structural chromatin loses its H3K9me3 marks as SIRT1 activity falls with NAD+.
Steve Horvath’s 2013 discovery (Genome Biology) identified 353 CpG sites whose methylation state predicts age with a median error of 3.6 years across all tissues. Subsequent clocks (GrimAge, DunedinPACE) refined this to predict mortality and pace of aging respectively.
The most important finding: epigenetic age is partially reversible.Yamanaka factor reprogramming (Oct4, Sox2, Klf4) resets methylation to embryonic patterns in mice — restoring vision and cognition. The Horvath/Sinclair “Information Theory of Aging” frames this as recoverable signal, not irreversible entropy. AKG supplementation in humans already shows 8-year epigenetic age reduction in a controlled trial.
Monitoring
Epigenetic clocks and biomarkers
Evidence-Graded Interventions
Epigenetic reprogramming with clinical evidence
Tier A = human RCT evidence. Tier B = at least one human trial + mechanistic data.
Calcium Alpha-Ketoglutarate (Ca-AKG)
Tier AAKG is an essential cofactor for TET2 dioxygenases — the enzymes that demethylate CpG sites and restore youthful methylation patterns. It also fuels the TCA cycle and is a key component of the α-ketoglutarate-dependent demethylase family (KDM2/4/6). A 2021 human trial (PMID: 33027664) showed 8-year reduction in biological age (Klemera-Doubal method) over 7 months.
NMN → SIRT1 Epigenetic Axis
Tier ASIRT1 and SIRT6 are NAD+-dependent deacetylases that stabilize heterochromatin by maintaining H3K9me3 and H4K16ac marks at pericentromeric regions. When NAD+ falls, SIRT1 activity collapses — heterochromatin dissolves, transposable elements reactivate, and the epigenetic age clock accelerates. NMN restores NAD+ and reactivates this epigenetic maintenance axis.
Resveratrol → SIRT1 Activation
Tier BResveratrol acts as an allosteric activator of SIRT1, increasing its affinity for acetylated substrates. SIRT1 then deacetylates H3K9ac at sites of heterochromatin disruption, re-silencing pro-aging gene expression. Most effective when combined with NMN/NR to ensure adequate NAD+ substrate.
Caloric Restriction / Fasting
Tier ACR resets age-related CpG methylation drift in rodents and nonhuman primates. In humans, the CALERIE trial (PMID: 31011460) showed reduced epigenetic age acceleration at 2-year follow-up. The mechanism involves AMPK/SIRT1 axis and reduced IGF-1/insulin signaling, which re-establishes youthful methylation maintenance.
Slow your epigenetic clock.
Build a Ca-AKG + NMN + resveratrol protocol and track your biological age with the Bio Age Engine.